Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

China flag China · Delayed Price · Currency is CNY
136.75
-1.50 (-1.08%)
At close: Feb 13, 2026
Market Cap12.15B +101.2%
Revenue (ttm)434.45M -17.6%
Net Income-259.33M
EPS-2.90
Shares Out88.83M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume999,513
Average Volume1,647,711
Open138.72
Previous Close138.25
Day's Range136.51 - 141.80
52-Week Range56.69 - 262.22
Beta1.57
RSI37.17
Earnings DateApr 25, 2026

About Beijing Hotgen Biotech

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers public safety solutions such as drug tasting, customs disease control, bioterrorism and food safety solutions. The company also provides clinical diagnostics and product solutions, including upconversion light, chemiluminescence, sugar capture, microfluidics, and genetic testing for testing of intestinal microorganisms, gastrointestina... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 850
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688068
Full Company Profile

Financial Performance

Financial Statements